best virtual currency to invest in, See results about

Li Ziyuan: The plan to reduce the holdings of directors, supervisors and senior managers has not been completed. Li Ziyuan announced the change. On October 1, 2024, the company disclosed the Announcement on the Plan to Reduce the Holdings of Some Directors, Supervisors and Senior Managers of Zhejiang Li Ziyuan Food Co., Ltd. Zhu Wenxiu and other six directors, supervisors and senior managers plan to reduce their holdings by centralized bidding, which does not exceed 1,190,607 shares, and does not exceed 1% of the company's total share capital. As of December 12, 2024, the above-mentioned directors, supervisors and senior managers reduced their holdings of 813,400 shares through centralized bidding. At present, the share reduction plan has not been completed. Huazhi Liquor Store: It is planned to distribute a cash dividend of 8.09 yuan for every 10 shares. Huazhi Liquor Store announced that the company's profit distribution plan for the first three quarters of 2024 has been approved by the shareholders' meeting. The company will distribute a cash dividend of RMB 8.09 to all shareholders for every 10 shares based on the existing total share capital of 417 million shares and the share capital of 408 million shares after 9,098,100 shares have been repurchased in the repurchase special securities account. The total amount of cash dividends actually distributed was 330 million. The distribution of rights and interests in date of record is December 19th, 2024, and the ex-dividend date is December 20th, 2024. This dividend does not involve bonus shares and capitalization of capital reserve.

Dong Yuhui has recently established three new companies. According to Tianyancha App, Zisan Province (Beijing) Technology Co., Ltd. was recently established, with the legal representative of Dong Yuhui and the registered capital of 10 million RMB. Its business scope includes Internet information services, value-added telecommunications services of the first kind, network culture management, film screening, alcohol management, radio and television program production and management, etc. According to the shareholder information, the company is jointly held by Zhongnan Yuantiao (Xi 'an) Technology Co., Ltd., Dong Yuhui and Long song Youhe (Beijing) Technology Partnership (Limited Partnership). It is worth mentioning that Zhongnan Yuantiao (Xi 'an) Technology Co., Ltd. and Long song Youhe (Beijing) Technology Partnership (Limited Partnership) were established recently with registered capital of 10 million RMB and 1 million RMB respectively.Summary of Hong Kong stock announcements, Small Vegetable Garden: It is planned to sell about 101 million shares worldwide, and it is expected to be listed on December 20. BOSS direct employment -W: The operating profit in the third quarter increased by 26.5%, and the monthly active users increased by 30%. BAIC Investment and Hyundai Motor injected US$ 1.095 billion into Beijing Hyundai in proportion. China Pacific Insurance: Pacific Life Insurance's premium income from January to November was 228.842 billion yuan. Year-on-year growth of 2.2% Hong Kong Science and Technology Exploration: In November, the total merchandise transaction volume of orders reached HK$ 687 million. SJM Holdings: It plans to acquire new quality digital technology in Hengqin New District, Zhuhai City for 546 million yuan. It plans to discount about 7.89% and place up to 800 million shares. Net raised HK$ 530 million. Kyle Digital Technology: It is planned to allocate a total of 212 million shares at a discount of about 15.38% to raise HK$ 210 million. Mongolian Mining: It is planned to spend US$ 20.5 million to acquire Mongolian copper exploration company and expand diversified mineral business. CGNPC New Energy: In November, the power generation was 1,360.8 GW, a year-on-year decrease of 18%.HKEx: It is estimated that the T+1 settlement system will be ready by the end of 2025.

Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.Yin Zhongyu, Federal Reserve Securities: Industrial M&A will always have the opportunity to cross-border M&A and will never be supported on a large scale. Yin Zhongyu, assistant to the president of Federal Reserve Securities and head of the M&A business department, pointed out that M&A has ushered in a rare policy window. For industrial M&A, the policy window has always been there. "In particular, industrial M&A focusing on new productivity has always been the direction encouraged by the regulatory authorities, and there will always be opportunities. However, for buying and selling shells and cross-border restructuring, related risks need to be vigilant, and cross- (21 Finance)CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.